|
|
|
|
|
|
最高研发阶段临床3期 |
首次获批国家/地区- |
首次获批日期- |
靶点- |
作用机制- |
|
原研机构- |
|
|
最高研发阶段临床阶段不明 |
首次获批国家/地区- |
首次获批日期- |
Effects of Quercetin on the Oxidative Stress and Inflammatory Markers in COPD Phase II
This study determines whether quercetin supplementation reduces the inflammation and oxidative stress markers in patients with chronic obstructive pulmonary disease. It is small study with 8 subjects receiving quercetin 1000 mg/day, 8 patients receiving 500 mg/day and 4 subjects receive placebo.
Single-arm Phase 2 Study of Oral Isoquercetin in Sickle Cell Disease
This research study is being done to assess the safety and effectiveness of isoquercetin to reduce levels of soluble P-Selectin in patients with sickle cell disease. Isoquercetin is a naturally occurring flavonoid-or vitamin. You will find quercetin and isoquercetin in fruits and vegetables.
The names of the study drug involved in this study are/is:
- Isoquercetin
Impact of Quercetin on Inflammatory and Oxidative Stress Markers in COPD
This study determines whether quercetin supplementation reduces the inflammation and oxidative stress markers in patients with chronic obstructive pulmonary disease. It is small study with 8 subjects receive quercetin 2000 mg/day and 4 subjects receive placebo.
100 项与 Quercegen Pharmaceuticals LLC 相关的临床结果
0 项与 Quercegen Pharmaceuticals LLC 相关的专利(医药)
100 项与 Quercegen Pharmaceuticals LLC 相关的药物交易
100 项与 Quercegen Pharmaceuticals LLC 相关的转化医学